There are many monoclonal antibodies for which the hybridoma cell line is unavailable. To complement our hybridoma sequencing service, we are also offering a de novo antibody protein sequencing service.
By combining mass-spectrometry with high-accuracy de novo peptide sequencing and assembly of overlapping peptides, the amino acid sequences of the variable domains are determined.
We guarantee to deliver a functional antibody sequence along with a comprehensive sequencing report with full sequence coverage. In combination with our transient expression service, we can sequence an antibody and deliver recombinant versions in as little as 9 weeks.
For more information please contact us.
|Customer provides||Mass Spectrometric Sequencing||Antibody Expression||Timeline||Deliverables|
|Monoclonal antibody, >0.1 mg, 95% pure||